Exhibit 99.1


                                                                     Page 1 of 2


                  Zynex Medical Appoints Peter J. Leveton Chief
                                Financial Officer
================================================================================

LITTLETON, Colo.

Zynex Medical
Thomas Sandgaard, 303-707-0203
or
The Wall Street Group, Inc.
Ron Stabiner, 212-888-4848


Zynex Medical Holdings (OTCBB: ZYNX) today announced the appointment of Peter J.
Leveton, a seasoned corporate executive, as the Company's Chief Financial
Officer, a newly created position.

Mr. Leveton, who has successfully served as Chief Executive Officer, Chief
Financial Officer and in other key senior management positions with public and
privately owned companies in the medical products and healthcare industries,
comes to Zynex most recently from Integrated Financial Systems, Inc., a Denver
healthcare financial services firm.

"Peter has a thorough background in all aspects of senior management, operations
and finance," stated Zynex President and Chief Executive Officer Thomas
Sandgaard. "His knowledge of corporate finance and all-around strategic planning
will make him a valuable asset to our management team as we plan and initiate
future expansion programs."

"This is an exciting time to be joining Zynex, which is entering a period of
anticipated growth with its proprietary line of pain management and non-invasive
products for medical patients," Mr. Leveton stated. "I am pleased to have the
opportunity to play a central role in planning and implementing the Company's
future."

Mr. Leveton's previous positions included Vice President Sales & Marketing with
Integrated Financial Systems; Chief Executive Officer with Surgical Acuity,
Inc., international manufacturer of dental and medical devices; President and
Chief Executive Officer of Romed Corporation, the developer and operator of
several outpatient healthcare facilities, and concurrently Vice President and
Treasurer of Rose Health Care System; and President and Chief Executive Officer
of Earth Sciences, Inc., a publicly owned chemical manufacturing and natural
resources company.

Mr. Leveton, 67, holds an MBA from New York University and a BA from Willamette
University in Salem, Ore.



                                                                     Page 2 of 2

About Zynex

Zynex, a leading provider of therapeutic devices for patients with functional
disability through the creation, distribution, and marketing of electrotherapy
devices since 1996, strives to uphold its mission to improve the quality of life
of patients suffering from debilitating pain or illness by providing innovative
technology. Utilizing a unique combination of electromyographic (EMG) technology
combined with a system of instruction and reinforcement, including electrical
muscle stimulation (EMS), Zynex offers new treatment options to post-stroke and
spinal injury patients.


Safe Harbor Provision

Certain statements in this release are "forward-looking" and as such are subject
to numerous risks and uncertainties. Actual results may vary significantly from
the results expressed or implied in such statements. Factors that could cause
actual results to materially differ from forward-looking statements include, but
are not limited to, the Company's ability to meet terms and conditions required
to obtain project financing, risks and delays associated with product
development, risk of market acceptance of new products, technology or product
obsolescence, competitive risks, reliance on development partners and additional
capital needs.